4 studies found for:    15930421 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Docetaxel in Combination With Doxorubicin and Cyclophosphamide (TAC) Versus 5-Fluorouracil in Combination With Doxorubicin and Cyclophosphamide (5 FAC) as Adjuvant Treatment of Breast Cancer Patients
Condition: Breast Neoplasms
Intervention: Drug: Docetaxel/Doxorubicin/cyclophosphamide (75/50/500) mg/m2 q3w
2 Terminated Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel, Anthracycline (Doxorubicin or Epirubicin), Cyclophosphamide;   Drug: Docetaxel, cyclophosphamide
3 Active, not recruiting Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer
Conditions: Breast Neoplasms;   Adjuvant;   Chemotherapy
Intervention: Drug: Docetaxel, Doxorubicin or Epirubicin, Cyclophosphamide
4 Completed
Has Results
Docetaxel in Node Positive Adjuvant Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Drug: 5-fluorouracil;   Drug: Doxorubicin;   Drug: Cyclophosphamide

Indicates status has not been verified in more than two years